Industry association · Spain · EU Transparency Register 746491933335-88
Counts here are a floor, never a total: they cover the 326 consultation files tracked so far (29,503 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Among the 1205 trade and business associations on this site, they rank #860 by legislative files engaged — a count of participation, not a measure of influence.
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026).
Self-declared to the EU Transparency Register (snapshot 30 Aug 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track Asociación in PolicySpeak: request access →
Work at Asociación Española de Medicamentos Biosimilares-BIOSIM? so we know who speaks for it.
Asociación Española de Medicamentos Biosimilares-BIOSIM filed 1 position on 26 Jan 2026, across 1 of the 326 legislative files tracked here, attaching a full position paper 1 time.
BioSim, the Spanish Association of Biosimilar Medicines representing companies that research, develop, produce or market biosimilars in Spain, sees this public consultation as an opportunity to make public procurement a strategic instrument and to reflect on how public procurement procedures can contribute to the sustainability of health systems, patient access to medicines and the resilience of the European…
Filed in Spanish · English published by the European Commission
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Everything on this page comes from Asociación Española de Medicamentos Biosimilares-BIOSIM’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.